18F-fluorodeoxyglucose and 131I radioguided surgical management of thyroid cancer.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21952355.
- Also identified by DOI 10.1177/0194599811423007.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To describe a technique that assists in the surgical management of recurrent local regional well-differentiated thyroid cancer (WDTC). Case series with chart review. Two academic health centers from 2001 to 2009. Patients operated upon by the senior surgeon (BCS) for recurrent WDTC. Thirteen patients with recurrent WDTC were operated upon with radioguided surgical (RGS) technique to indentify recurrence for excision. Eight patients had iodine avid disease and were candidates for RGS with (131)I. The remaining 5 patients had cancer with a proven loss of iodine avidity and were, therefore, operated upon with a fluorodeoxygluocose (FDG) RGS technique. RGS is a feasible approach to identify recurrent disease in an operated field and ensure its successful excision. Although focal disease may be identified with this technique, this is not a tool for limited excisions ("berry picking").
Medical subject headings
- Fluorodeoxyglucose F18
- Positron-Emission Tomography
- Radiosurgery
- Thyroid Neoplasms